Ariad leukemia drug helps 47 percent of patient: study

SAN DIEGO (Reuters) – Early results from a pivotal trial of Ariad Pharmaceuticals Inc's experimental leukemia drug ponatinib show it is effective in nearly half of patients who had stopped responding to currently available drugs. An interim lo…

View full post on Yahoo! Health News

, , , , , ,

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Get Adobe Flash player

Powered by Yahoo! Answers

© 1992-2012 DC2NET™, Inc. All Rights Reserved